About March Biosciences
March Biosciences is a private company based in Houston, Texas, incorporated in 2021 in Delaware. It has reported $22,149,812 raised in two offerings on Form D since September 2023. Its chief executive is Sarah Hein.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 7, 2024 | Oct 22, 2024 | $22,140,942fully sold | 22 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Sep 1, 2023 | Sep 12, 2023 | $8,870fully sold | 1 | $8,870 | OptionsRule 506(b) | Form D ↗ |
| Total, two offerings | $22,149,812 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on March Biosciences's Form D filed Oct 22, 2024.
TL
Thomas Luby
Director
PO
Peter Olagunju
Director
JP
Joseph Petrosino
Director
SH
Sarah Hein
Co-Founder, Chief Executive Officer and director
MM
Maksim Mamonkin
Executive officer and director